Bayer tries to buy Monsanto: Absent a crystal ball, what’s the LuxTake?

German chemical and pharmaceutical giant Bayer ignited the agribusiness industry what-if machine in May with its offer to purchase Monsanto. This is yet another mega-merger in the industry, following the Dow and DuPont merger and China National Chemical Company’s acquisition of Syngenta. Neither ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

AgBiome raises $116 million Series D led by Blue Horizon

News Commentary | September 16, 2021

With the funding, AgBiome will expand its portfolio, cement its global presence, and scale its scientific and commercial teams. AgBiome has now generated two products with its discovery platform: Howler, a broad‑spectrum fungicide with 10× sales growth in 2020, and Theia, a second fungicide ... Not part of subscription

Marrone Bio Innovation merging with Bioceres Crop Solutions is an smart strategy for biological product portfolio expansion

Case Study | May 12, 2022

In March 2022, Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that they would merge in an all‑stock transaction. Bioceres also recently acquired Rizobacter, an established biological and chemical solutions platform for crop ... Not part of subscription

Solis Agrosciences launches transgenic plants as a service

News Commentary | May 19, 2022

Solis Agrosciences will provide gene editing and plant transformation services — Plant Pipeline as a Service —‑ to agritech research centers and startups. It aims to reduce pain points associated with high barriers of entry from equipment, expertise, and inefficient workflows. The company claims to ... Not part of subscription